CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
1,708.00
-28.00 (-1.61%)
Nov 7, 2025, 3:30 PM KST
CMG Pharmaceutical Market Cap
CMG Pharmaceutical has a market cap or net worth of 252.51 billion as of November 7, 2025. Its market cap has decreased by -15.24% in one year.
Market Cap
252.51B
Enterprise Value
260.61B
Revenue
94.73B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,708.00
Market Cap Chart
Since March 1, 2002, CMG Pharmaceutical's market cap has increased from 11.27B to 252.51B, an increase of 2,140.64%. That is a compound annual growth rate of 14.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 7, 2025 | 252.51B | 2.83% |
| Dec 30, 2024 | 245.56B | -26.64% |
| Dec 28, 2023 | 334.73B | 12.09% |
| Dec 29, 2022 | 298.62B | -43.94% |
| Dec 30, 2021 | 532.65B | -33.65% |
| Dec 30, 2020 | 802.80B | 36.00% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.09T |
| ALTEOGEN | 28.24T |
| SK Biopharmaceuticals | 9.08T |
| Yuhan | 8.62T |
| Peptron | 6.67T |
| HLB Co., Ltd. | 6.25T |
| ABL Bio | 5.58T |